Akums Drugs IPO listing: Shares make muted debut on BSE, NSE; Book profit?

The grey market premium (GMP) for Akums Drugs IPO shares rose by nearly 7 per cent ahead of the listing on the BSE and NSE, indicating moderate listing gains for investors